10 Best Clean Energy Stocks To Watch For 2015

According to GuruFocus list of 5-year lows, these Guru stocks have reached their 5-year lows: Rentech Nitrogen Partners LP, Francesca�� Holdings Corp, American Residential Properties Inc, Silver Bay Realty Trust Corp, and Western Asset Mortgage Capital Corp

Rentech Nitrogen Partners LP (NYSE:RNF) Reached the 5-year Low of $16.02

The prices of Rentech Nitrogen Partners LP (NYSE:RNF) shares have declined to close to the 5-year low of $16.02, which is 68.9% off the 5-year high of $49.18. Rentech Nitrogen Partners LP is owned by one guru we are tracking. Among them, none have added to their positions during the past quarter. 1 reduced their positions. Rentech Nitrogen Partners LP is a limited partnership formed by Rentech, a publicly traded provider of clean energy solutions and nitrogen fertilizer, to own, operate and grow nitrogen fertilizer business. Rentech Nitrogen Partners Lp has a market cap of $623.019 million; its shares were traded at around $16.02 with and P/S ratio of 2.02. The dividend yield of Rentech Nitrogen Partners Lp stocks is 7.80%.

5 Best Diversified Bank Stocks To Own Right Now: Arch Capital Group Ltd.(ACGL)

Arch Capital Group Ltd., together with its subsidiaries, provides insurance and reinsurance products worldwide. It operates in two segments, Insurance and Reinsurance. The Insurance segment offers casualty; construction; executive assurance; healthcare; collateral protection, debt cancellation, and service contract reimbursement products; national accounts casualty; professional liability; programs; property, energy, marine, and aviation; surety; and travel and accident insurance products. It also provides other insurance products, such as excess workers compensation and employers' liability insurance coverages for qualified self-insured groups, associations, and trusts; captive insurance programs; and accident, disability, and medical plan insurance coverages for employer groups, medical plan members, students, and other participant groups. This segment markets its products through a network of licensed independent retail and wholesale brokers. The Reinsurance segment rei nsures third party liability and worker?s compensation exposures; individual property risks that include personal lines and commercial property exposures; other specialty lines, including surety, accident and health, workers' compensation catastrophe, multi-peril crop, trade credit, and political risk; catastrophic perils, such as hurricane, earthquake, flood, tornado, hail, and fire; marine business, which includes coverage for hull, cargo, and transit and offshore oil and gas operations, as well as aviation business that comprises coverage for airline and general aviation risks; and non-traditional business to provide insurers with risk management solutions. This segment markets its reinsurance products through brokers, as well as directly with the ceding companies. The company was founded in 1995 and is headquartered in Hamilton, Bermuda.

Advisors' Opinion:

• [By Ben Levisohn]

  For the past several years, Berkshire has contrasted its own cost-free float provided by profitable underwriting against the industry�� (unimpressive) tendency to lose money on underwriting while generating net returns from investment income. So far, so good. Less edifying, though, is the repeated contrast of Berkshire�� track record of profitability to State Farm��…even though, as a mutual company, State Farm�� profitability goals are inherently different from for-profit insurers like Berkshire. It�� true that through year-end 2013, Berkshire�� underwriters have ��ow operated at an underwriting profit for eleven consecutive years,��but so have ACE (ACE), American Financial (AFG),� AmTrust Financial (AFSI), Arch Capital (ACGL), Chubb (CB), HCC (HCC), Progressive (PGR), RLI (RLI), and W.R. Berkley (WRB), any or all of whom provide a more meaningful comparison than contrasting Berkshire�� results to a company that�� not out to produce a profit in the first place.

• [By Holly LaFon]

  Arch Capital (ACGL)'s Dinos Iordanu recently described to our analysts how he met me in 2001. Before we invested in his business, we asked him all sorts of personal questions about how he came to America from Cyprus; whether or not his wife had a job; and how big was his house? He told our analysts that "Ron was trying to get a sense of me. He wanted to understand how I viewed risk. No one else asked us such questions. They were the right questions since you were investing in our business, which was assuming underwriting risk on your behalf. "We got it right with Dinos and have about quadrupled our money in the past twelve years, not exactly the most propitious time to invest in stocks! Of course, there can be no assurance that future investments will be as profitable��lthough you can be assured that we will continue to work hard to try to achieve similar results.

10 Best Clean Energy Stocks To Watch For 2015: Core Laboratories N.V. (CLB)

Core Laboratories N.V. engages in the provision of reservoir description, production enhancement, and reservoir management services to the oil and gas industry worldwide. The company�s reservoir description services comprise the characterization of petroleum reservoir rock, fluid, and gas samples; and provision of analytical and field services to characterize properties of crude oil and petroleum products. Its production enhancement products and services relate to reservoir well completions, perforations, stimulations, and production, as well as include integrated services to evaluate the effectiveness of well completions and to develop solutions to increase the effectiveness of enhanced oil recovery projects. The company�s reservoir management services consist of the combination and integration of information from reservoir description and production enhancement services to increase production and enhance recovery of oil and gas from clients' reservoirs. Core Laboratori es N.V. markets and sells its services and products through sales representatives, technical seminars, trade shows, and print advertising, as well as through direct sales force, technical experts, operating managers, sales representatives, and distributors in various markets. The company was founded in 1936 and is based in Amsterdam, the Netherlands.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Equities Trading DOWN
  Shares of Core Laboratories NV (NYSE: CLB) were 18.47 percent to $154.17 after the company lowered its forecast for the second quarter and FY14.

• [By ovenerio]

  The company has a current ROE of 15.65% which is higher than the one exhibit by Superior Energy Services Inc (SPN) and National Oilwell Varco Inc (NOV). In general, analysts consider ROE ratios in the 15-20% range as representing attractive levels for investment. So for investors looking for those levels or more, Oceaneering International�(OII) could be the option and Core Laboratories NV�(CLB) tremendous ratio seems very attractive. It is very important to understand this metric before investing and it is important to look at the trend in ROE over time.

10 Best Clean Energy Stocks To Watch For 2015: SOHM Inc (SHMN)

SOHM, Inc. is a global generic pharmaceutical manufacturer, developer and marketer having a range of products, covering the therapeutic segments. The Company has its presence in healthcare segments, such as nutraceuticals, dermatology and all other therapeutic segments.

The Company�� generic pharmaceuticals are exported globally with a focus on distribution in Africa, Latin America and Southeast Asia. The Company�� products has presence in analgesic, anti-flammatory, drops, suspensions, vitamins and tonics, antibiotics, beta-lactum antibiotics, injections, syrups, anti-cold, capsules, nutraceutical and tablets.

Advisors' Opinion:

• [By Peter Graham]

  Small cap stocks VizStar Inc (OTCMKTS: VIZS), SOHM Inc (OTCMKTS: SHMN) and American Soil Technologies, Inc (OTCMKTS: SOYL) have been getting some attention in various investment newsletters with two out of three of these stocks being the subject of paid promotions. However, there is nothing wrong with some paid for attention so long as everything is properly disclosed, but its going to be up to investors and traders alike to ultimately decide whether any of these stocks have what it takes to be the next hot stock. With that in mind, here is a quick reality check about all three small cap stocks:

10 Best Clean Energy Stocks To Watch For 2015: Katy Industries Inc (KATY)

Katy Industries, Inc. (Katy) is a manufacturer, importer and distributor of commercial cleaning and storage products. The Company�� commercial cleaning products are sold primarily to janitorial/sanitary and foodservice distributors that supply end users, such as restaurants, hotels, healthcare facilities and schools. The Company�� storage products are primarily sold through home improvement and mass market retail outlets. Continental Commercial Products, LLC (CCP) is its wholly owned subsidiary and includes as divisions all of its business units. The Company�� business units are Continental, Contico, Container, Gemtex, Glit and Wilen. On October 4, 2011, the Company sold all assets and certain liabilities related to the DISCO division of CCP to DISCO Acquisition Corp. In February 2014, Katy Industries Inc completed the acquisition of Fort Wayne Plastics, Inc.

The Continental business unit is a plastics manufacturer and an importer and distributor of products for the commercial janitorial/sanitary maintenance, industrial and food service markets. Continental products include commercial waste receptacles, buckets, mop wringers, janitorial carts, and other products designed for commercial cleaning and food service. Continental products are sold under the brand names, such as Continental, Kleen Aire, Huskee, SuperKan, King Kan, Unibody, Tilt-N-Wheel, Wall Hugger, Collossus, Corner��Round, Rountop, Swingline, Kleen Tech and Structo Tuff.

The Contico business unit is a plastics manufacturer and distributor of home and tool storage products, sold primarily through home improvement and mass market retail outlets. Contico products include plastic home storage units, such as domestic storage containers, tool boxes, shelving and hard plastic gun cases and are sold under the brand names Contico and Tuffbin. Contico is a registered trademark used under license from Contico Manufacturing Limited.

The Container business unit is a plastics manufacturer and distributor ! of industrial storage drums and pails for commercial and industrial use. Products are sold under the Contico and Contico Container brand names.

The Gemtex business unit is a manufacturer and distributor of resin fiber disks and other coated abrasives for the original equipment manufacturer (OEM), automotive, industrial and home improvement markets. Gemtex products are sold under the brand names Trim-Kut and Grind R.

The Glit business unit is a manufacturer and distributor of non-woven abrasive products for commercial and industrial use and also supplies materials to various OEMs. Glit non-woven products include floor maintenance pads, hand pads, scouring pads, specialty abrasives for cleaning and finishing, growth medium and roof ventilation products. These products are sold primarily in the commercial sanitary maintenance, food service, industrial and construction markets under the brand names, such as Glit, Kleenfast, Glit/Microtron, Fiber Naturals, Blue Ice, Brillo, Cyclone, Cyclone D, Sponge Pro, Wipe Clean Pro, Joey, Jackeroo, Buckaroo, Cocopad, Safire and WalnutPad. Brillo is a registered trademark used under license from Armaly Brands, Inc. and BAB-O is a registered trademark used under license from Fitzpatrick Bros., Inc.

The Wilen business unit is a manufacturer, importer and distributor of professional cleaning products that include mops, brooms, brushes and plastic cleaning accessories. Wilen products are sold primarily through commercial sanitary maintenance, industrial and food service markets, with some products sold through consumer retail outlets. Products are sold under the brand names, such as Wilen, Wax-o-matic, Rototech, ErgoWorx and Derma-Tek.

Advisors' Opinion:

• [By Chris Mydlo]

  The guru, Mario Gabelli, purchased 724,729 shares of Katy Industries (KATY). According to the 13D filed with the SEC on March 21, 2014, Gabelli is deemed to have beneficial ownership of the securities owned by Gabelli Funds, GAMCO, Teton Advisors and MJG Associates. The total amount of shares owned is 1,711,045, representing 21.52% of the shares outstanding. Katy engages in the manufacture, import and distribution of commercial cleaning and storage products for commercial janitorial/sanitary maintenance, industrial, foodservice, mass merchant retail and home improvement markets in the U.S., Canada and Europe.

10 Best Clean Energy Stocks To Watch For 2015: Patterson Companies Inc.(PDCO)

Patterson Companies, Inc. operates as a distributor serving the dental, companion-pet veterinarian, and rehabilitation supply markets in North America. Its Dental Supply segment provides consumable dental supplies, such as x-ray film and solutions; impression and restorative materials; hand instruments; sterilization products; anesthetics; infection control products, including protective clothing, gloves, and facemasks; paper, cotton, and disposable products; toothbrushes; dental accessories; printed office products, office filing supplies, and practice management systems; x-ray machines, handpieces, dental chairs and handpiece control units, diagnostic equipment, dental lights, compressors, chair-side restoration systems, and inter-oral cameras; practice management and clinical software; hardware and networking solutions; and patient education solutions. The company?s Veterinary Supply segment offers consumable supplies, such as lab supplies, paper goods, needles and syr inges, gauze and wound dressings, sutures, latex gloves, and orthopedic and casting products; pharmaceuticals comprising anesthetics, antibiotics, ointments, and nutraceuticals; diagnostics; biologicals, including vaccines and injectibles; and equipment and software. Its Rehabilitation Supply segment provides dressing and grooming devices, and toileting, dining, and bathing aids; braces, splints, and orthotics; exercise bands, putty, weight balls, and mats; walkers, canes, and wheelchair accessories; rolls, wedges, seating and standers, and mobility assistance products; motor stimulation products; products for heating and cooling therapies, electrical stimulation, laser, ultrasound, paraffin, iontophoresis, and therapeutic creams and lotions; and rehabilitation equipment and software. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is based in St. Paul , Minnesota.

Advisors' Opinion:

• [By Seth Jayson]

  Patterson Companies (Nasdaq: PDCO  ) reported earnings on May 23. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended April 27 (Q4), Patterson Companies met expectations on revenues and met expectations on earnings per share.

• [By Vera Yuan]

  During the quarter, the Fund initiated positions in eight companies and strategically added to positions in sixteen companies. Over the same time period, the Fund eliminated its holdings in six companies and strategically decreased its holdings in another five companies. Positions initiated during the last three months include: Dorman Products, Inc. (DORM), Dover Corp. (DOV), DSW Inc. (DSW), First Niagara Financial Group (FNFG), Packaging Corporation of America (PKG), Patterson Companies, Inc. (PDCO), The Travelers Companies Inc. (TRV), and Universal Health Services Inc (UHS). Positions eliminated during the past quarter include: ABB Ltd. (ABB), Ann Inc. (ANN), Baxter International (BAX), International Game Technology (IGT), TRW Automotive Holdings (TRW), and URS Corporation (URS).

• [By Eric Volkman]

  Patterson (NASDAQ: PDCO  ) has elected not to raise its quarterly shareholder payout. The company today declared a regular stock dividend of $0.16 per share, to be paid on July 26 to shareholders of record as of July 11. That amount matches the company's previous distribution, which was paid at the end of April. Before that, Patterson handed out $0.14 per share.

10 Best Clean Energy Stocks To Watch For 2015: ONEOK Partners L.P.(OKS)

ONEOK Partners, L.P. engages in the gathering, processing, storage, and transportation of natural gas in the United States. The company?s Natural Gas Gathering and Processing segment gathers and processes natural gas produced from crude oil and natural gas wells located in the Mid-Continent region; and gathers natural gas in the Williston Basin, which spans portions of Montana and North Dakota, and the Powder River Basin of Wyoming. Its Natural Gas Pipelines segment primarily owns and operates regulated natural gas transmission pipelines, natural gas storage facilities, and natural gas gathering systems for non-processed gas. It also provides interstate natural gas transportation and storage services. This segment?s interstate natural gas pipeline assets transport natural gas through FERC-regulated interstate natural gas pipelines in North Dakota, Minnesota, Wisconsin, Illinois, Indiana, Kentucky, Tennessee, Oklahoma, Texas, and New Mexico. In addition, it transports intra state natural gas through its assets in Oklahoma; and owns underground natural gas storage facilities in Oklahoma, Kansas, and Texas. Its Natural Gas Liquids segment gathers, fractionates, and treats natural gas liquids (NGLs), as well as stores NGL products primarily in Oklahoma, Kansas, and Texas. This segment owns FERC-regulated natural gas liquids gathering and distribution pipelines in Oklahoma, Kansas, Texas, Wyoming, and Colorado; terminal and storage facilities in Missouri, Nebraska, Iowa, and Illinois; and FERC-regulated natural gas liquids distribution and refined petroleum products pipelines in Kansas, Missouri, Nebraska, Iowa, Illinois, and Indiana that connect its Mid-Continent assets with Midwest markets, including Chicago, Illinois. ONEOK Partners GP serves as the general partner of the company. The company was formerly known as Northern Border Partners, L.P. and changed its name to ONEOK Partners, L.P. in May 2006. The company was founded in 1993 and is based in Tulsa, Oklahoma.

Advisors' Opinion:

• [By David Dittman]

  Answer: ONEOK is running wild in anticipation of its completion of transactions that will make it essentially a general partner, with interests in ONEOK Partners LP (NYSE: OKS) and the soon-to-be-spun-out ONE Gas Inc (NYSE: OGS). ONEOK already has an admirable record of dividend growth, and these moves will drive acceleration in 2014 payout growth.

• [By Aimee Duffy]

  Midstream companies are having an excellent 2013 so far, but ONEOK Partners (NYSE: OKS  ) has more or less missed out, as shares are down about 1% year to date. The partnership and its general partner ONEOK (NYSE: OKE  ) report earnings on Tuesday, and the results will hopefully shed some light on whether or not things will pick up this year. Here are three things to watch for when ONEOK Partners reports.

10 Best Clean Energy Stocks To Watch For 2015: Synergy Pharmaceuticals Inc (SGYP)

Synergy Pharmaceuticals, Inc., incorporated on February 11, 1992, is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. The Company�� lead product candidate is plecanatide, a guanylyl cyclase C (GC-C), receptor agonist, to treat GI disorders, primarily chronic constipation (CC), and constipation-predominant-irritable bowel syndrome (IBS-C). It is also developing SP-333, the second generation GC-C receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis (UC). The Company�� active pharmaceutical ingredients (APIs) and the final formulated drug products are manufactured for it by third party contractors.

As of December 31, 2011, the Company was developing plecanatide, a synthetic hexadecapeptide designed to mimic the actions of the GI hormone uroguanylin, for the treatment of CC and IBS-C. Plecanatide is an agonist of GC-C receptor. As of December 31, 2011, the Company was dosing patients in an 800-patient Phase II/III clinical trial of plecanatide to treat. It is also developing a second generation GC-C receptor analog, SP-333, which is in pre-clinical development for the treatment of gastrointestinal inflammatory diseases. SP-333 is a synthetic analog of uroguanylin, a natriuretic hormone.

The Company competes with Ironwood Pharmaceuticals, Inc., Forest Laboratories, Inc., Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Shire Plc.

Advisors' Opinion:

• [By Monica Gerson]

  Breaking news

  Time Warner Cable (NYSE: TWC) reported a drop in its third-quarter profit. Time Warner Cable's quarterly profit fell to $532 million, or $1.84 per share, from $808 million, or $2.60 per share, in the year-ago period. To read the full news, click here. Synergy Pharmaceuticals (NASDAQ: SGYP) today announced the start of a phase 2 clinical trial to evaluate the safety and efficacy of SP-333, its second-generation GC-C agonist and once-daily oral treatment, in adult patients with opioid-induced constipation (OIC). To read the full news, click here. Cigna (NYSE: CI) reported a 19% rise in its third-quarter earnings and lifted its full-year earnings outlook. To read the full news, click here. Charm Communications (NASDAQ: CHRM) announced today that the special committee of the Company's board of directors, consisting of independent directors Mr. Zhan Wang, Mr. Andrew J. Rickards and Mr. Gang Chen, has retained China Renaissance Securities (Hong Kong) Limited as its financial advisor and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP as its legal advisor. To read the full news, click here.

  Posted-In: Bank of America US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

• [By Sean Williams]

  Finally, Synergy Pharmaceuticals (NASDAQ: SGYP  ) may have had the wildest week of them all. Synergy's share price spiked 16% on Tuesday as an analyst at Cantor Fitzgerald raised her peak sales estimate for plecanatide, the company's midstage drug for chronic idiopathic constipation and irritable bowel syndrome with constipation, to $1.58 billion from $1.05 billion, as clinical data has been stronger than expected. However, the company didn't return the favor to shareholders by -- the very next day, mind you ��announcing a secondary offering of 16.375 million shares. The downside of clinical-stage companies is the always apparent risk of dilution. Shares have lost 25% since their Tuesday close.